 SAN DIEGO, May 17, 2022 GLOBE NEWSWIRE -- Bionano Genomics, Inc. BNGO, pioneer of optical genome mapping OGM solutions on the Saphyr system and provider of NxClinicalTM software, the leading solution for visualization, interpretation and reporting of genomic data, today announced its virtual participation in the 2022 H.C. Wainwright Global Investment Conference. Erik Holmlin, PhD, Bionanos president and chief executive officer, will present a company overview available for on-demand listening starting Tuesday, May 24, 2022, at 7:00 a.m. Eastern Time. Interested parties can register for the conference and view the presentation here: 